基本信息
views: 91
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Mirjam van der Burg, PhD started her own research group on Primary Immunodeficiency (PID) after she completed her PhD in 2002 on “Recombination processes during B-cell differentiation”. The group started as part of the unit Molecular Immunology of the Dept. of Immunology at the Erasmus MC, Rotterdam. The strength of her group is the combination of diagnostics and research on PID, especially on severe combined immunodeficiency (SCID), DNA repair disorders and antibody deficiencies. She has good interactions and a strong link with treating physicians and is able to make the bridge to fundamental Immunology. In this way she set up strong collaborations and a good network in the PID field. With her team she identified four new genetic defects in PID i.e. CD19, CD81 deficiency in antibody deficiency and LIG4 and DNA-PKcs in SCID was involved in description on the first XRCC4 deficiencies. For her paper on DNA-PKcs deficiency she received the Best Publication Award of the Molecular Medicine Research School. Together with her clinical partners at the Erasmus MC, the PID group became a JMF center of excellence PID care and research in 2010 and has recently been acknowledged as national center of expertise for rare diseases, which is now recognized as Center of Expertise by the NFU. At the Erasmus MC, she developed good PID trainings programs and since 2011 she is actively involved in international teaching activities as faculty member of the ESID Summer School and the Freiburg Workshop on PID diagnostics. She contributed as author to the definitions of the international guideline for neonatal screening for SCID based on TRECs (CLSI). She is actively involved in implementation of neonatal screening for SCID in the Netherlands, which is the first country in Europe who decided to include TREC screening in the national screening program. Furthermore she is actively involved in the EuroFlow program as workpackage leader of the PID group for development of standardized flowcytometric analysis. In 2013 she received an Aspasia Grant for talented female scientists. She is active member of the Dutch Workgroup of Immunodeficiencies and since November 2014, she is member of executive board of ESID (Secretary). She received prestigious research grants of the national research council (Veni and Vidi grants) for her research projects on V(D)J recombination and immune receptor repertoire formation and the role of DNA repair in these processes and recently a JMF Translational research grant Award for her research on DNA repair disorders: integrating genomics and functional studies for developing diagnostic and therapeutic approaches together with Kaan Boztug from Vienna. She published more than 125 manuscript in international peer reviewed journals and contributed to the PID texts book of Ochs and Stiehm/Sullivan. Furthermore she is active as reviewer for several journals and is member of the editorial board of Journal of Clinical Immunology and Frontiers in Immunology.
Research Interests
Papers共 249 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
biorxiv(2024)
Isaac Kistler,Amy Gaviglio, Dianne Rosemary Webster, Jennifer Taylor,Monica Lawrence,Anne Pham-Huy,Joyce Yu,Lisa Kobrynski,Jennifer Heimall,Jennifer Puck,Mirjam van der Burg,Fabian Hauck,
Clinical Immunology (2024): 109987
SCANDINAVIAN JOURNAL OF IMMUNOLOGYno. 1 (2024): e13335-e13335
International journal of molecular sciencesno. 21 (2023): 16012
European journal of pediatricsno. 9 (2023): 4195-4203
Clinical and Experimental Immunology (2023)
Research Square (Research Square) (2023)
Load More
Author Statistics
#Papers: 249
#Citation: 10189
H-Index: 54
G-Index: 94
Sociability: 7
Diversity: 3
Activity: 77
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn